In-vitro
The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro.
Rocky Lowenthal, Megan Taylor, Jennifer A Gidden, Billie Heflin, Jackson O Lay, Nathan Avaritt + 2 more
In-vitroBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2023
vote to see if the hive agrees
Research Facts
The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro.
Rocky Lowenthal, Megan Taylor, Jennifer A Gidden, Billie Heflin, Jackson O Lay, Nathan Avaritt + 2 more
In-vitro · Preliminary · 2023 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Findings

Turkey tail mushroom extract killed melanoma cancer cells in lab tests, with the mycelium (root structure) being significantly more potent than the fruiting body. It triggered cancer cell death through multiple mechanisms and slowed cancer cell migration, suggesting potential as a melanoma treatment—but this is early-stage lab work, not yet tested in humans.

Design: In-vitro
Evidence: Preliminary
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Methodology

Researchers exposed human melanoma cancer cells to turkey tail mushroom extracts in petri dishes and measured how effectively the extracts killed the cancer cells and disrupted their behavior.

Funded By

Funding not disclosed in abstract